Navigation Links
World Debut for BSP's HyperQ Stress System: 57th Annual American College of Cardiology Meeting 2008
Date:3/25/2008

TEL AVIV, Israel, March 25 /PRNewswire/ -- BSP Ltd. (http://www.bsp.co.il/pressall.asp), an Israeli company which develops and markets systems for non-invasive diagnosis and monitoring of ischemic heart disease, will be launching their HyperQ(TM) Stress System in the US during the 57th Annual ACC 08 Meeting in Chicago, IL.

The HyperQ(TM) is cutting-edge technology implemented in an innovative stress-test system, offering highly reliable, low-cost and risk free cardiac monitoring for broad populations and allows, for the first time, effective and accurate testing for Ischemic heart disease patients.

The HyperQ(TM) system received FDA clearance (510K), as well as the European CE marking. To date, more than 3500 patients in Israel, Europe and the US have been examined by HyperQ(TM) Stress Systems in controlled clinical studies, pilot programs and routine testing in the setting of private offices and hospital clinics. The results have demonstrated the system's high efficiency and unmatched accuracy in the diagnosis of IHD.

The company has entered the clinical and commercial phase, during which the HyperQ(TM) Stress System will be integrated in inpatient settings, outpatient cardiology departments, private doctor offices and major research centers.

Further applications on the company's scope, based on the same core technology, include bedside monitors for ischemic events; devices for cardiac home-care and telemedicine; periodic check-up systems, and the implementation of the HyperQ(TM) technology in implantable cardiac devices such as pacemakers and defibrillators.

Dr. Amir Beker, CEO of BSP says, "BSP's HyperQ(TM) technology is a revolutionary solution to today's most fatal pathology. The HyperQ(TM) Stress System is a non-invasive solution that will improve the standard of care for cardiac patients and at the same time will help reduce unnecessary costly and potentially harmful procedures. The HyperQ(TM) Stress System thus addresses dire needs of private and national healthcare systems to balance the immense costs of cardiac diagnosis and monitoring, while decreasing the risk of further, often invasive, tests for cardiac patients".

About BSP

BSP is dedicated to providing novel, risk free and highly reliable solutions for the diagnosis and monitoring of Ischemic Heart Disease. BSP was founded in 2000 by Dr. Amir Beker and Mr. Ariel Landau and has completed a successful IPO in mid-2006 and its shares are traded on the Tel Aviv Stock Exchange.

Contact: Dr. Amir Beker, +972-3-6474840, http://www.bspmedical.com


'/>"/>
SOURCE BSP - Biological Signal Processing Ltd
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Nanoscience will change the way we think about the world
2. The Lancet Publishes Results From Worlds First Clinical Trial of a Fully Bioabsorbable Drug Eluting Coronary Stent
3. Mentice AB Announces Leadership Changes Within Its Worldwide Operations
4. ChanTest to Highlight Expanded Ion Channel Testing Services for Preclinical Safety at ToxExpo, Including the Worlds Largest Catalog of Validated Ion Channels, Booth 2504
5. Royea Joins Eklin Medical Systems as VP of Worldwide Sales
6. Sirion Therapeutics Acquires Worldwide License to Develop New Treatment for Ocular Diseases
7. Experts and Representatives From Leading International Health-Care Organizations Call to Stop the Hypertension Pandemic, a Worldwide Silent Killer
8. Maryland Science Center Unveils Anatomical Exhibition, Body Worlds 2, on Saturday, February 2
9. Starion Achieves Worldwide Distribution of Proprietary Tissue Welding Technology
10. World Glaucoma Day Set for March 6th
11. Cascade Microtech Introduces Worlds First 45 nm-capable DC/RF Parametric Probe Card Solutions, Lowers Cost of Ownership
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... ... January 19, 2017 , ... FireflySci Inc. is a go-getter type of company ... is accounted to two main factors. The first is the amazing customer service ... supplying FireflySci products all around the world. , 2016 was a tremendous sales year ...
(Date:1/19/2017)... 18, 2017  Northwest Biotherapeutics, Inc. (OTCQB: NWBO) ("NW ... therapies for operable and inoperable solid tumor cancers, announced ... Officer of NW Bio, will present at the Phacilitate ... the Hyatt Regency Hotel in Miami, Florida ... session entitled "New Therapeutic Approaches – Expanding the Reach ...
(Date:1/18/2017)... ... January 18, 2017 , ... Opal Kelly, a leading ... PCI Express, announced the ZEM5310 USB 3.0 FPGA Module, combining a SuperSpeed USB ... sized form factor suitable for prototyping, testing, and production-ready integration. The ZEM5310 USB ...
(Date:1/18/2017)... LINCOLN, Mass. , Jan. 18, 2017 /PRNewswire/ ... in applying mechanistic modeling to drug research and ... , PhD, Co-Founder, President, and CEO of Applied ... Group for Informatics and Modeling (BAGIM) Meeting on ... in Cambridge , MA.   Dr. ...
Breaking Biology Technology:
(Date:12/15/2016)... 15, 2016  There is much more to innovative ... the engine. Continental will demonstrate the intelligence of today,s ... . Through the combination of the keyless entry ... biometric elements, the international technology company is opening up ... authentication. "The integration of biometric elements brings ...
(Date:12/12/2016)... Dec. 12, 2016  Researchers at Trinity College, ... graphene by combining the material with Silly Putty. The ... pressure detector able to sense pulse, blood pressure, ... spider.  The research team,s findings ... read here:  http://science.sciencemag.org/content/354/6317/1257 ...
(Date:12/8/2016)...  Singulex, Inc., the leader in Next Generation Immunodiagnostics ... license and supply agreement with Thermo Fisher Scientific, the ... access to Thermo Scientific BRAHMS PCT (Procalcitonin), a biomarker ... to diagnose systemic bacterial infection and sepsis and in ... in assessing the risk of critically ill patients for ...
Breaking Biology News(10 mins):